Abstract
Background Digital proximity tracing (DPT) apps have been released to mitigate SARS-CoV-2 transmission. But it remains unclear how their acceptance and uptake can be improved. The aim of this study was to investigate SwissCovid app coverage and reasons for not using the app in Switzerland during a time of increasing SARS-CoV-2 incidence.
Methods By use of data collected between 28.09.2020 to 08.10.2020 for a nationwide online panel survey (Covid-19 Social Monitor, n=1’511 participants), socio-demographic and behavioral factors associated with app usage were examined using multivariable logistic regression. Reasons for app non-use were analyzed descriptively.
Results Overall, 46.5% of participants reported using the SwissCovid app (up from 43.9% in a study wave conducted in July 2020).
A higher monthly household income (e.g. OR 1.92 [1.40-2.64] for an income >CHF 10’000 vs. an income ≤ CHF 6’000), more frequent internet use (e.g., daily (reference) vs. less than weekly OR 0.37 [0.16-0.85]), better adherence to mask-wearing recommendations (e.g., always or most of the time (reference) vs. rarely or never OR 0.28 [0.15-0.52]), and being a non-smoker (OR 1.32 [1.01-1.71]) were associated with an increased likelihood for app uptake. Citizenship status (e.g., non-Swiss citizenship 0.61 [0.43-0.87] vs. Swiss citizenship only), and language region (French 0.61 [0.46-0.80], vs. Swiss German) were associated with a lower app uptake probability.
In a randomly selected subsample (n=711) with more detailed information, higher levels of trust in government and health authorities were additionally associated with a higher app uptake probability (e.g., OR 3.13 [1.58-6.22] for high vs. low trust (reference)).
The most frequent reasons for app non-use was lack of perceived benefit of the app (36.8%), 22.8% reported to have no compatible phone, and 22.4% had privacy concerns.
Conclusion Removing technical hurdles and communicating the benefits of DPT-apps are crucial to promote further uptake, compliance, and ultimately to enhance effectiveness of DPT-apps for pandemic mitigation.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The Social Monitor study has received funding from the Federal Office of Public Health and from Health Promotion Switzerland. The Funders have no influence on the design, conduct, analyses, and publications.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
For the Covid-19 Social Monitor, the Ethics Committee of the Canton Zurich confirmed that it does not fall under the Swiss Human Research Law (BASEC-Nr. Req-2020-00323). Therefore, informed consent was not needed.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Completely updated analysis using new data from the Covid-19 Social Monitor. Removal of analyses based on Corona Immunitas study to streamline paper. Editing of paper for clarity, coherence. Key messages were not altered.
Data Availability
The datasets generated during and/or analysed during the current study are available from the corresponding author on reasonable request.
